Bioprocess Technology Market is estimated to be US$ 19.9 billion by 2022 with a CAGR of 12.5%

Author: Ritvi Kadam

Bioprocess technology is the industrial application of biological processes to achieve desired substrate transformation using living cells or their constituent units, the main advantages of using bioprocesses over conventional chemical processes is that they produce renewable by-products. Bioprocessing is a combination of biology, mathematics and engineering that includes activities such as bioreactors, biocatalysts, substrates and media volume production, downstream processing and purification. Bioprocessing technology is likely to see significant demand from the pharmaceutical sector, due to the increasing incidence of chronic diseases such as infections and cancer. Bioprocess is a specific process that uses whole living cells or their components such as bacteria, enzymes, chloroplasts to obtain desired products. The most important applications of bioprocess-engineering research and development related to agriculture and food include yield, and biological pesticides and herbicides; Enhancing bioprocesses. Bioprocess technology is an important part of biotechnology that deals with the process of converting all living matter or its constituents into nutrients along with specialized chemicals, reagents and bio therapeutics, these processes form the backbone of translating life science discoveries into useful industrial products. The development of several next-generation biopharmaceutical products using bioprocess technology has increased the interest in the bioprocess technology industry over the past few years, the growth of this market is mainly attributed to funds raised for research and development of bioprocessing technologies, increase in production of vaccines and continuous technological advancements in bioprocessing.

The report "Bioprocess Technology Market, By Type (Flow Cytometry, Cell Expansion, Cell line Development, Virus Infiltration), By Application (Biopharmaceuticals, Specialty Products and Industrial Chemicals, Environmental Management aid), End-Users (Biotechnology & Biopharmaceutical Companies, Research & Academic Institutes, Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032"

Key Highlights:

  • In November 2022, a multinational team of researchers developed a process that builds on the success of the current reverse osmosis process that removes salt from seawater. The researchers, led by Professor Heqing Jiang of the Chinese Academy of Sciences' Qingdao Institute of Bioenergy and Bioprocess Technology, published their findings in November 2022 in Nano Research.
  • In November 2022, using Raman spectroscopy techniques, scientists from the Chinese Academy of Sciences' Qingdao Institute of Bioenergy and Bioprocess Technology directly identified carbon-dioxide-fixing cells, or cells that take in CO2 from seawater, indicating bacteria involved in photosynthesis.

Analyst View:

Bioprocess technology is one of the most important and useful in various fields, the major advantages of bioprocesses over conventional chemical processes are that they require milder reaction conditions, are more specific and efficient, and produce renewable by-products, the development of recombinant DNA technology has expanded and enhanced bioprocess capacity. Bioprocess engineering in the agricultural and food industry involves the use of biocatalysts (living cells or their components) to produce useful and value-added products and offers the opportunity to design and manufacture new or improved agricultural and food products and their production processes. Bioprocess technology market innovation is increasing worldwide, with technological advancements in bioprocess technology making it more efficient to use.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

Key Market Insights from the report:

Bioprocess Technology Market accounted for US$ 19.85 billion in 2022 and is estimated to be US$ 56.1 billion by 2032 and is anticipated to register a CAGR of 12.5%. The Bioprocess Technology Market is segmented based on Type, Application, End-User and Region.

  • Based on Type, Bioprocess Technology Market is segmented into Flow Cytometry, Cell Expansion, Cell line Development, Virus Infiltration.
  • Based on Application, Bioprocess Technology Market is segmented into Biopharmaceuticals, Specialty Products and Industrial Chemicals, Environmental Management aid.
  • Based on End-User, Bioprocess Technology Market is segmented into Biotechnology & Biopharmaceutical Companies, Research & Academic Institutes, Others.
  • By Region, the Bioprocess Technology Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Bioprocess technology Market:

The prominent players operating in the Bioprocess Technology Market includes, Millipore Sigma, Danher Life Sciences, GE Healthcare, Lonza-Pharma & biotech, Thermo Fisher Scientific, Sartorius Stedim Biotech, Asahi Kasei Medical, Solesis Medical, Charles River laboratories, Solid Biotech GmBH. The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.